Sat, Jun 24, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
New Managers July 2012

Servicers' Spot IMS: New funds must not be disheartened by the regulatory challenges

Peter Moore

Peter Moore is head of compliance and regulation for the IMS Group, a global compliance group for the asset management and securities industry. Its clients include many of the world's largest hedge fund managers, private equity firms, fund of funds managers, family offices and institutional pension fund managers.

He talked to Opalesque about the regulatory and compliance challenges that new hedge funds are facing now, and advises them not to be discouraged by the new, demanding requirements.

"Over the last few years, column inches have been taken up by the many political and regulatory responses to the financial crisis," he said. "We have the responses in the US with the Dodd-Frank Wall Street Reform and Consumer Protection Act, and then in the UK where there is a very large number of new initiatives and new directives coming from Europe in order to respond to the financial crisis, such as those relating to short selling, central clearing for OTC derivatives and a new regime for some managers and distributors of alternative funds."

In his career, he has never seen such a level of change. But this is not a brick wall.

"The key message to any start-up is that none of the challenges, whether they be old or new regulatory challenges, are insurmountable. They all have a few basic themes which are: integrity within the financial market, the fair treatment of clients and investors and the supply of information. Despite all the regulation and the cost to comply with it, if a new firm has a business case for starting up a new venture, a new fund, it must not be distracted or disheartened by the regulatory challenges it faces. These are all surmountable with the right ad......................

To view our full article please login

This article was published in Opalesque's New Managers a top-down monthly analysis, news and research publication on the global emerging manager space.
New Managers
New Managers
New Managers

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. FinTech - Rise of robots: Inside the world's fastest growing hedge funds[more]

    From Bloomberg.com: Believe the hype. Quants have never been more popular. After doubling over the past decade, assets run by so-called systematic funds have hit a record $500 billion this year, according to estimates from Barclays Plc. In some ways, their meteoric rise is due to the same technolog

  2. Legal - Bond market concerns could scuttle Paulson's Fannie-Freddie plan[more]

    From Bloomberg.com: A hedge fund proposal for freeing Fannie Mae and Freddie Mac from U.S. control is poised to face stiff opposition from investors who say it risks wrecking the mortgage-bond market. The Moelis & Co. blueprint, which firms including Paulson & Co. and Blackstone Group LP sponsored,

  3. Other Voices: Are your pricing policies and procedures for less liquid instruments adequate?[more]

    Komfie Manalo, Opalesque Asia: The unrelated position mismarking incidents that quickly precipitated the closures of both Visium Asset Management and Marinus Capital have been recent focal points for market participants, but regulatory scrutiny of valuation choices for less liquid instruments is

  4. FinTech - AI hedge fund Numerai now live on Ethereum, Cryptocurrency hedge funds generate huge returns as bitcoin surges[more]

    AI hedge fund Numerai now live on Ethereum From Cryptoninjas.net: Back in February, Numerai announced numeraire (NMR), a cryptographic token to incentivize a new kind of hedge fund built by a network of data scientists. Earlier today, the Numeraire smart contract was officially deployed

  5. Investing - Advisors slash hedge fund positions, Theravance Biopharma is a top pick of investment guru Seth Klarman, As asset management industry grows a search for new revenue streams[more]

    Advisors slash hedge fund positions From Barrons.com: Financial advisors have cut wealthy clients' exposure to hedge funds by up to one third over the past 12 months, The Financial Times reports. Advisor firms in the FT's annual top-300 ranking have reduced their hedge fund allocation to